Advanced BioMedical Technologies, Inc. (ABMT)

ABMT Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jul 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017	Oct 31, 2016
Net Income	-0.75	-0.67	-0.95	-0.95	-0.69	-0.72
Depreciation & Amortization	0.08	0.06	0.02	0.02	0.01	0.03
Loss (Gain) From Sale of Assets	0	0	-	-	-	-
Loss (Gain) From Sale of Investments	-	-	-	-	0.04	-
Stock-Based Compensation	0.04	0.05	0.02	0.05	-	0.05
Other Operating Activities	-0.01	0.02	0.01	0.01	0.02	0.02
Change in Accounts Receivable	-0.01	0.02	-0.02	-0.02	0	-0
Change in Inventory	-0.1	-0.03	-0.07	-	-	0
Change in Accounts Payable	0.65	1.19	0.24	0.05	0.06	0.25
Change in Other Net Operating Assets	0.11	0.01	0	-	-	-
Operating Cash Flow	0.01	0.65	-0.74	-0.83	-0.56	-0.37
Capital Expenditures	-0.05	-0.03	-0.02	-0.06	-0	-0
Other Investing Activities	-	-	-	-	0	-
Investing Cash Flow	-0.05	-0.03	-0.02	-0.06	0	-0
Short-Term Debt Issued	-	0.07	0.76	0.93	0.61	0.39
Total Debt Issued	0.51	0.07	0.76	0.93	0.61	0.39
Short-Term Debt Repaid	-	-0.45	-	-0.03	-0.05	-0.05
Long-Term Debt Repaid	-	-0.04	-	-	-	-
Total Debt Repaid	-0.48	-0.49	-	-0.03	-0.05	-0.05
Net Debt Issued (Repaid)	0.02	-0.42	0.76	0.9	0.56	0.34
Other Financing Activities	-0	-0	-	-	-	-
Financing Cash Flow	0.02	-0.43	0.76	0.9	0.56	0.34
Foreign Exchange Rate Adjustments	0.01	0.01	-0	-0	0	-0
Net Cash Flow	-0.01	0.2	-0	-0	0	-0.03
Free Cash Flow	-0.04	0.62	-0.76	-0.9	-0.56	-0.37
Free Cash Flow Margin	-39.45%	498.40%	-6529.08%	-	-	-
Free Cash Flow Per Share	-0.00	0.01	-0.01	-0.01	-0.01	-0.01
Cash Interest Paid	-	0	-	-	-	-
Levered Free Cash Flow	0.43	0.88	-0.41	-0.61	-0.37	-0.2
Unlevered Free Cash Flow	0.62	1.08	-0.2	-0.42	-0.21	-0.04
Change in Working Capital	0.65	1.19	0.16	0.04	0.07	0.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.